Sep 29

SS 27 - Advances in Multimodal Therapy for Glioblastoma: From Phase I to Phase III Trials

241 - Initial outcomes from a phase II study of multiparametric MR-guided high-dose response adaptive radiotherapy with concurrent temozolomide in patients with newly diagnosed glioblastoma

01:10pm - 01:20pm ET

Presenter(s)

Michelle Kim, MD - University of Michigan, Ann Arbor, Michigan